Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Intangibles (2022 - 2025)

GeneDx Holdings (WGS) has disclosed Intangibles for 4 consecutive years, with $176.7 million as the latest value for Q2 2025.

  • On a quarterly basis, Intangibles changed N/A to $176.7 million in Q2 2025 year-over-year; TTM through Jun 2025 was $176.7 million, a N/A change, with the full-year FY2024 number at $158.6 million, down 8.12% from a year prior.
  • Intangibles was $176.7 million for Q2 2025 at GeneDx Holdings, up from $158.6 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $186.6 million in Q4 2022 to a low of $158.6 million in Q4 2024.
  • A 4-year average of $173.3 million and a median of $174.4 million in 2023 define the central range for Intangibles.
  • Peak YoY movement for Intangibles: decreased 7.51% in 2023, then dropped 8.12% in 2024.
  • GeneDx Holdings' Intangibles stood at $186.6 million in 2022, then dropped by 7.51% to $172.6 million in 2023, then fell by 8.12% to $158.6 million in 2024, then increased by 11.41% to $176.7 million in 2025.
  • Per Business Quant, the three most recent readings for WGS's Intangibles are $176.7 million (Q2 2025), $158.6 million (Q4 2024), and $169.1 million (Q1 2024).